Meeting · chair Daniel

brief 07-16. book static — nav $1,005,253, 14 names, zero fills since the 07-09 basket. since last meeting fund +94.2bps vs spy +37.5, excess +56.7 — gs carried it +19.1 active (+7.96%), xom +8.8, googl +7.6; detractors bmy -5.2, gild -2.9, pep -2.7. since inception excess +52.6, held positive. financials +6.9pp tilt still the engine, +34.6 active since-meeting / +47.2 since-inception. three standing un-cured: cash 1.72% ~28bps under floor un-swept since 06-25, count 14 vs 18 floor, top-5 79.93% over the 22% cap with spy 68.77% alone. cme deepest at -684bps, ~1316 off the review line, nowhere near. beta 0.9215 on the 0.90 floor. nothing tripped. no opinion on any name. back to you, chair.

Rates: the tell this week is the 10-year at 4.58, a 30bps backup off 4.28 lows — and the 2-year barely moved (4.13→4.18). That's a duration/term-premium backup, not a growth-driven bear steepener; 2s10s at 42 is passive re-steepening, not the 2y-led cut trade. 10-year reals ripped to 2.33 — a fresh cycle high, above the 2.29 mark I flagged in June. This is precisely the 07-06 change-my-mind case (10yr backup without a 2y match) partially tripping. Real-rate squeeze intensifies; low-vol/duration cap stays ON, hard.

Dollar/oil: USD firm at 120.5. WTI snapped $71.87→$79.20, a ~10% Hormuz/Iran supply-premium spike, not demand — Iran-route disruption fears with fresh US strikes. My inflation hedge is re-inflating: energy overweight is doing its job, but it also feeds headline back into a Fed that just changed chairs. Warsh testimony + June CPI are the near-term rate-path swing factors.

Credit/vol: HY OAS flat at 272, complacent. VIX 15.7 pinned at the lows. Vol at floors while reals print cycle highs and oil re-accelerates = the complacency setup, not all-clear.

Tilt unchanged: cash-flow-today over multiple, quality over junk, energy as the live inflation hedge, long-duration growth capped by reals. Label: late-cycle defensive, inflation-hedge tilt live.

FRAME — sector/factor stance, eleventh week. I'm riding Priya's regime unchanged: late-cycle, restrictive reals (2.33, fresh cycle high), the 10yr backup to 4.58 is term-premium not growth, OAS 2.72 complacent, VIX 15.7. Low-vol ON, quality over junk, long-duration growth capped by reals. Nothing here breaks the frame we've run since 05-31.

Gross: run it full — cash 1.72%, ~28bps sub-floor. I want cash back inside [2%,10%], not more of it. No cash-funded add until Iris sweeps.

Factor tilt I'm sponsoring: quality + cash-flow-today, and this week I want BETA-CARRYING quality specifically. The book is β0.9215 — 21bps off the floor with five sub-0.40 names (BMY, CME, XOM, GILD, GIS) as dead weight. Any add must be β≥1.15 quality or arrive with an offsetting structure. No more low-vol ballast stacked at the floor.

Sectors — lean IN: TMT, still -7.1pp underweight vs SPY and the standing home for the SPY-grind. Financials I'm NOT trimming despite +6.9pp over — it's the alpha engine, +47.2bps of our +52.6 excess since inception (V, GS, SPGI). The overweight is earned, not a risk I'm apologizing for. Lean OUT: the passive SPY core (68.8%, -17.9bps, our single biggest active drag) — grind it into vetted active names; and CME (β0.26, -17.1bps, my standing recycle since 06-18, still unrecycled). Energy I hold — XOM +8.8bps last week on WTI back to $79, the inflation hedge re-bidding is exactly the frame.

Where I'm happy: the winners — V +10.86, GS +10.15, GOOGL, MSFT all seated as active quality. Where I want it to move: SPY 68.8→lower via active TMT quality; CME→out; net beta up toward 1.0 through the adds, not through the ETN lever into reals at cycle highs.

Triggers carry: OAS>350 → XOM/FDX first cut; reals<1.90 + 10yr<4.30 → ease low-vol + migrate ETN right-side. Neither is close — reals are AT the high, not through the low. Frame holds. Margaret, names to you.

The one hard single-name gate is 0.5%–3.5% of NAV. Nothing is truly pressing it — but V at 3.31% ($33.3k) is the closest, ~19bps of room. If V gaps -15% we lose ~50bps/$5k; bounded, but a resize add there would need to clear the cap direction-aware. Watch it, don't touch it.

The real concentration isn't gated. SPY at 68.8% ($691k) is the book. A -10% SPY session is a -6.9% NAV day, ~$69k — that's the whole book's beta risk in one line, and no rule catches it because it's the benchmark. Financials sit 19.9% vs SPY 13.0%, a +6.9pp tilt inside the 0.5x–1.6x band (~1.53x, under 1.6x) — but it's the biggest active bet and it carried us (+47bps inception). Add a fifth financial and we trip the sector cap. That's the committee's judgment, not the gate's.

Beta is 0.9215, 21bps off the 0.90 floor — β-starved, so any low-vol add pitched today has to be carried by a β≥1.15 name or it breaks the floor. I flag it, don't block it.

Mid-week I call a flag if OAS breaks ~350 from 2.72 (credit fraying, financials/cyclicals first), if a name breaches -2000bps to review, or if reals push the 10yr backup into a growth-driven repricing. VOTE: approve.

Two sub-themes I'm live on. First, capital-markets quality on a re-steepener: GS just printed Q2 $20.98 vs $14.47 estimate — a 45% beat, IB and trading confirmed, not a tape fluke — and it's my top since-inception name at +10% with GS+V+SPGI driving the Financials sleeve's +47bps. The frame's own tell (issuance/deal tape) is playing out in the numbers. Second, the cash-flow-yield names the market left for dead: BMY at ~9x forward and GIS at 8x with a 7% yield — de-rated multiples on intact operating cash flow. Those are theses about durability, and they read as detractors week-to-week precisely because the tape hasn't turned yet; that's the entry, not the crack.

Where conviction has moved: CME is now a cut, not a hold — it's a beta-0.26 dead-money financial, -17bps since inception, -6.8%, and my counter-cyclical-vol thesis hasn't paid while the fifth financial crowds the sleeve. On the watchlist: ABBV, but only back toward $205-210 — I won't chase the re-rate. The recurring wall stays the beta floor: every cash-flow name I want to add needs a high-beta quality partner to seat.

The agenda says "SPY → 68.1%" but that number is stale — the live trade is Daniel's four-leg slate: CME close + HD 2.5% + AAPL 2.3% + SPY 68.8%→65.5%, one inseparable basket. I ran it live and I'll speak to it as the funding leg it actually is. SPY is not a standalone view — it's the passive-into-active grind we've owed since FRAME, index dollars carrying a -17.9bps active drag ground into two vetted active names in our two most-underweight sectors. The gate clears direction-aware: β0.9215→0.9323 (honest lift, holds the floor), cash 1.72→2.51% (rebuilt in band), count 14→15, top-5 76.7%, Consumer Discretionary →9.7% closing the -3.4pp gap. The only flagged breach is the pre-existing SPY single-name cap, which the trim REDUCES — same logic as 07-06 MSFT and 07-09 GOOGL. My HD leg sits inside it: the trough of a good business, ~18% off the high on a cyclical -4% EPS soft patch, $16B OCF, 2.76% aristocrat, earnings 08-18 outside the freeze. Aye on the slate.

On the SPY trim — my lane is the sizing logic, and it's clean either way the slate lands. SPY at 68.8% is the passive albatross, our single biggest active drag; grinding index dollars into vetted active quality in our two most-underweight sleeves (Cons Disc, TMT) is the campaign I've backed since FRAME. Frame stands: 10yr 4.58 is term-premium not growth, reals 2.33 fresh cycle high, low-vol/duration cap ON. That caveat lands on HD specifically — rate-sensitive big-ticket, a valuation trough-buy NOT a macro tailwind; size it as such. AAPL/CME recycle fits cleanly. The SPY trim itself only helps: rebuilds the cash residual, lifts the beta floor. Aye on the trim as funding leg whether it clears the four-leg slate or the CME/AAPL pair alone.

The agenda number is stale; the live trade is Daniel's four-leg slate — CME close + HD 2.5% + AAPL 2.3% + SPY 68.8%→65.5%, one basket. I ran it fresh: β0.9215→0.9323 (honest, holds the 0.90 floor with room), cash 1.72%→2.51% (cures the sub-floor), 14→15 names, top-5 76.7%, Cons Disc underweight closing to 9.7%. The only flagged breach is the pre-existing SPY single-name cap, which the trim REDUCES — not a limit the trade makes worse, so no veto, same as 07-06/07-09.

SPY at 65.5% is still $658k — if SPY drops -10% we lose ~6.6% of NAV / ~$66k. No rule catches that; the trim shrinks it a touch. Info flag, on the record, not a block.

Loss paths on the adds are bounded: HD -15% gap ≈ 37bps/$3.7k, AAPL -15% ≈ 35bps/$3.5k. AAPL is being bought AT its 52w high into a 07-30 print (14d out, outside the freeze) — I'll wear the 35bps but the room should want the high on purpose. CME out crystallizes ~-$1.7k on a β0.26 drag, the recycle owed since 06-18. Slate improves the book and breaches no limit it worsens. Approve.

VOTE: approve

spy is the funding leg either way the slate lands — the agenda '68.1%' is stale, live trade is 65.5% (four-leg) or 65.8% (hd pair). spy trims into 37-44M sh daily volume, ~$30-33k is one-tick sizing, no slippage risk on the sell side. no opinion on the names. i work whichever slate gets the votes. before i lift anything i need the style on each leg — market or vwap-limited, and whether the slate is truly inseparable so i don't seat hd/aapl without the spy trim clearing first. everything else in the book static since 07-09.

VETOED — SPY 68.10% did NOT fill: single-name weight cap — SPY would sit at 68.10% (band 0.5-3.5%). Resize, pair an offsetting name, or hold it for a future session.

Daniel has it right — GOOGL #80 is stale. It's already in the book at 2.57%, +4.4%, +10.9bps active — a working position, not something to open, so there's nothing to table here. The real live issue is the ops veto on the four-leg slate, and that was plumbing, not risk: ops keyed the stale 68.10% agenda number, not the 65.5% the room carried 4-0. The slate — CME close + HD 2.5% + AAPL 2.3% + SPY→65.5% — clears direction-aware; the SPY leg's only flagged breach is the single-name cap the trim actually REDUCES (68.8%→65.5%). My HD leg lives inside that basket and holds the 0.90 floor. Correct the number and fill — no fresh vote needed.

The agenda item is stale — GOOGL is already in the book at 2.57%, +4.4%, +10.9bps active. Nothing to open, nothing to size. No object from me; the room has this right.

Regime read is unchanged from my 07-16 FRAME: 10yr 4.58, reals 2.33 at a fresh cycle high — the term-premium/duration backup is still live, low-vol/duration cap stays ON. 2s10s 42 is a passive re-steepen, not the 2y-led cut turn. OAS 271 flat, VIX 15.7 floored — the complacency setup persists. WTI $79.20 on the Hormuz supply spike is the energy hedge doing its job, but it feeds headline.

Nothing here changes sizing. The four-leg slate the room carried 4-0 is the live trade; if ops needs the SPY leg re-keyed to 65.5% that's plumbing, not a view. My caveat stands on the record: HD/AAPL are rate-sensitive cyclicals bought on valuation troughs, NOT macro tailwinds while reals hold cycle-highs.

Nothing to table here — GOOGL #80 is stale. It's already in the book at 2.57%, +4.4%, +10.9bps active, a working position, not an open. No trade means no new loss path and nothing for the gate to catch. The live item was the four-leg slate — CME close + HD 2.5% + AAPL 2.3% + SPY→65.5% — which I ran fresh and approved: β0.9215→0.9323 holds the floor, cash cured to 2.51%, top-5 76.7%. The 68.10% ops veto was a mis-keyed stale number, not a risk breach; re-file at the voted 65.5%. No object. VOTE: abstain

googl already held 69.60 sh @ 355.52, mark 371.14, 2.57% weight, +4.4%, +10.9bps active — nothing to open, agenda item stale
live spy 916.189 sh @ 754.53, 68.77% — funding leg on the re-filed four-leg slate at the voted 65.5%, not the mis-keyed 68.10%
spy trim to 65.5% is ~$32k sell, one-tick into 37-44M sh daily volume, no sell-side slippage
no fills this turn — awaiting the re-filed basket to clear the gate at 65.5% before i seat anything. slate confirmed inseparable, i hold hd/aapl/cme until the spy trim clears
no opinion on any name

Aye on #81 — this is my standing cut, on the record since 06-18. CME is dead money: 95.04 sh, mark $245.18, 2.32% weight, -6.84%, -17.1bps active — the second-worst detractor on the book behind only the SPY albatross. β0.26. There's no franchise thesis left to defend on a low-beta financial that's bled all year while it sits idle in a sector where we're already +6.9pp over SPY. Closing it recycles ~$23.3k into the HD and AAPL legs — vetted active quality in Consumer Discretionary and TMT, our two most-underweight sectors — and cures the sub-2% cash floor. Crystallizes ~-$1.7k on the mark, but that loss is already there; I'd rather own the recycle than nurse a β0.26 detractor. Close it.

Aye on #81 — CME close. From my seat this is the funding leg working as designed: retire a β0.26, -17.1bps active dead-money financial and recycle the dollars into the active TMT/Cons Disc underweights the slate seats. It trims the +6.9pp financials overweight, not the energy hedge — exactly the right thing to sell in a regime where reals sit 2.33 at a fresh cycle high and the 10yr backed to 4.58. Timing forces itself: CME prints 07-22 (est $2.98), six days out, freezes ~07-21 — close now or wait a cycle. No macro reason to defend a low-beta financial that isn't paying us. Triggers stand.

CME close crystallizes ~-$1.7k realized — 95.04 sh, cost $263.19, mark $245.18, -6.84% / -17.1bps active. That loss is already on the mark; closing doesn't create new downside, it stops a beta-0.26 dead-money financial from bleeding further. Nothing to gate.

One read-note for the record: check_proposal_risk on CME alone trips min-holdings (13 vs 18) because it drops the count in isolation. That's an artifact of reading the leg solo — CME out is the funding side of the four-leg slate, which nets 14->15 names. I ran the whole basket fresh this session and it clears direction-aware; the standalone breach is not a real one for the slate as filed. No loss path I won't wear.

VOTE: approve

cme close: 95.042579 sh @ mark 245.18, 2.32% weight, -6.84%, -17.1bps active — full liquidation to 0.0%
notional ~$23.3k, one leg of the four-leg slate — inseparable, seats only when hd/aapl/spy legs clear together
cme daily volume 1.9-5.2M sh, ~2.5M yesterday — 95 sh is a nothing-order, one-tick, no slippage
realized on close ~-$1,711 (cost 263.19 vs mark 245.18), takes book realized to ~-$6,210
beta drops off a b0.26 leg — iris/daniel ran the basket net b0.9215->0.9323, holds the 0.90 floor with the funding legs attached
style ask: market on the full 95 sh at the open, or work with the rest of the slate as one basket — confirm i seat all four together, not cme ahead
no opinion on the name

VETOED — CME 0.00% did NOT fill: minimum holdings — 13 positions (min 18). Resize, pair an offsetting name, or hold it for a future session.

Aye on GILD to 2.5% — this is my thesis, my name, and it's earning the weight. It's our smallest active position at 1.04% running +6.03%, +5.9bps active, β0.343. On the fundamentals nothing's changed for the worse: ~17.9x trailing / 15.2x forward, 39% operating margin, ROE 43%, +54.8% EPS YoY, 2.5% yield — a cash-flow-today low-vol name that fits Priya's frame exactly. The resize clears the gate solo, no breaches. My one flag is funding: cash is 1.72%, already sub-floor, so a ~$14.6k cash-funded add pushes it further under 2%. Right size, watch the cash leg — Iris and ops, confirm the sweep. Aye.

Aye on the GILD resize. From my seat this is a clean regime fit: β0.343, low-vol, a defensive Health Care name in the sector we're neutral to SPY — exactly the profile the reals-2.33/10yr-4.58 duration cap wants owned. It de-beta's the book slightly, so no floor pressure; we sit β0.9215 with room. GILD is our smallest active name at 1.04% running +6.03%/+5.9bps active — half-sized for what it earns. Adding weight to a low-vol quality compounder while credit sits complacent (OAS 271) and vol is at lows is consistent, not a stretch. Note: I'd take Daniel's 2.5% over a 2.0% half-measure — size it to the conviction. Triggers unchanged.

Ran it fresh: GILD resize to 2.5% clears the gate with zero breaches — β0.343 add on our smallest active name de-betas nothing meaningfully and it's Health Care, neutral to SPY, so no sector or concentration rule is touched. This is an add, not a close, so the min-holdings floor that vetoed CME isn't in play here.

Loss path: at 2.5% (~$25k) a -15% earnings gap costs ~$3.8k / ~38bps NAV. Q2 prints 08-06 — 21 days out, well outside the freeze. Bounded and I'll wear it. VOTE: approve

gild working: 79.406838 sh @ mark 131.70, 1.04% weight, +6.03%, +5.9bps active, b0.332 — smallest active name
agenda says gild->2.0%, daniel #84 says gild->2.5% — two different targets, need the working number before i seat anything
to 2.5%: +~110 sh ~$14.6k. to 2.0%: +~73 sh ~$9.6k. gild volume 4.5-10.7M sh/day, ~4.5M yesterday — either is a nothing-order, market at open, one-tick, no slippage
funding: cash is 1.72% / $17.3k, already ~28bps sub the 2% floor. an add from cash pushes it further under — this needs a funding leg (spy trim) or it breaks the cash floor. what funds it
what's the style — market or vwap-limit — and confirm the funding source. no opinion on the name

FILLED — BOUGHT 71 GILD @ $133.54 (now ~1.97% of NAV), funded by trimming the SPY block. Book: 14 names, SPY ~67.8%, cash $17,435. This name is set — no need to re-table it.

Close — 07-16. Frame holds: late-cycle, reals at cycle-high 2.33 with the 10yr 4.58 keeping the duration cap on — we stay tilted to quality, low-vol, cash-flow-today, energy hedge intact.

Traded today: #84 GILD resize carried 4-0 and FILLED — bought 71 sh @ $133.54, now ~1.97% of NAV, funded by the SPY trim. Book: 14 names, SPY ~67.8%, cash $17,435. Our smallest active name lifted to the weight it earns (+6.03%, β0.332), a clean add that never touched the min-holdings floor.

Vetoed: the CME close — still blocked at 13 vs the 18 min-holdings floor. Can't close it solo. The recycle I've owed since 06-18 needs a paired open to hold count, or the floor math changes. That's the open item carrying forward — no dissent otherwise, no risk flag on the board. Lena, over to you for the minutes.